Christopher McKown files SEC Form 4 disclosures for Oaktree Specialty Lending Corp. They have made 1 open-market trade across 1 company since 2023, most recently 2023-03-17.
CIK 0001895260
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $18K since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| OCSL | 5,092 | $59K |
Shares reported on the most recent Form 4, priced at the 2023-03-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OCSL | BUY | 2023-03-17 | 2023-03-20 | $17.79 | $18K | +1.8% | +3.1% | +5.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.